IONIS PHARMACEUTICALS INC financial data

Symbol
IONS on Nasdaq
Location
Carlsbad, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 29 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 429% % -41%
Quick Ratio 2% % -73%
Debt-to-equity 412% % -33%
Return On Assets -9% % 30%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 161,974,393 shares 2.6%
Common Stock, Shares, Outstanding 161,137,930 shares 2.1%
Entity Public Float $5,738,934,243 USD 35%
Common Stock, Value, Issued $161,000 USD 1.9%
Weighted Average Number of Shares Outstanding, Basic 159,765,000 shares 7.5%
Weighted Average Number of Shares Outstanding, Diluted 159,765,000 shares 7.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $226,577,000 USD -30%
Revenue from Contract with Customer, Excluding Assessed Tax $966,957,000 USD 20%
Costs and Expenses $1,245,004,000 USD 6.1%
Operating Income (Loss) $278,047,000 USD 25%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $258,722,000 USD 27%
Income Tax Expense (Benefit) $2,380,000 USD -179%
Net Income (Loss) Attributable to Parent $256,342,000 USD 29%
Earnings Per Share, Basic -1 USD/shares 34%
Earnings Per Share, Diluted -1 USD/shares 31%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $338,341,000 USD 1.1%
Inventory, Net $10,470,000 USD -63%
Other Assets, Current $243,744,000 USD 32%
Assets, Current $2,518,993,000 USD -7.2%
Property, Plant and Equipment, Net $106,117,000 USD 29%
Operating Lease, Right-of-Use Asset $241,993,000 USD 47%
Other Assets, Noncurrent $165,988,000 USD 38%
Assets $3,033,091,000 USD -1.6%
Accounts Payable, Current $14,326,000 USD 58%
Employee-related Liabilities, Current $57,019,000 USD 41%
Accrued Liabilities, Current $99,310,000 USD -20%
Contract with Customer, Liability, Current $76,986,000 USD 1.3%
Liabilities, Current $903,456,000 USD 197%
Contract with Customer, Liability, Noncurrent $107,906,000 USD -38%
Operating Lease, Liability, Noncurrent $262,672,000 USD 56%
Other Liabilities, Noncurrent $28,785,000 USD -31%
Liabilities $2,415,124,000 USD -0.14%
Accumulated Other Comprehensive Income (Loss), Net of Tax $25,978,000 USD -7.5%
Retained Earnings (Accumulated Deficit) $2,401,801,000 USD -12%
Stockholders' Equity Attributable to Parent $617,967,000 USD -6.7%
Liabilities and Equity $3,033,091,000 USD -1.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $150,775,000 USD -0.56%
Net Cash Provided by (Used in) Financing Activities $2,199,000 USD -91%
Net Cash Provided by (Used in) Investing Activities $170,459,000 USD 124%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 161,137,930 shares 2.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $22,115,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $338,341,000 USD 1.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities $92,000 USD -3.2%
Deferred Tax Assets, Valuation Allowance $1,129,708,000 USD 16%
Deferred Tax Assets, Gross $1,174,111,000 USD 14%
Operating Lease, Liability $170,869,000 USD -4.5%
Depreciation $2,228,000 USD -13%
Payments to Acquire Property, Plant, and Equipment $12,577,000 USD 180%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $258,147,000 USD 23%
Lessee, Operating Lease, Liability, to be Paid $260,238,000 USD -6.9%
Operating Lease, Liability, Current $9,064,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid, Year Two $21,032,000 USD 1.9%
Lessee, Operating Lease, Liability, to be Paid, Year One $20,870,000 USD 2.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $89,369,000 USD -11%
Lessee, Operating Lease, Liability, to be Paid, Year Three $21,054,000 USD 1.3%
Deferred Tax Assets, Operating Loss Carryforwards $95,851,000 USD 23%
Unrecognized Tax Benefits $41,161,000 USD -4.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four $20,973,000 USD 0.83%
Amortization of Intangible Assets $582,000 USD -8.9%
Share-based Payment Arrangement, Expense $126,702,000 USD 5.2%
Interest Expense $16,626,000 USD -4.2%